FI953851A - Silybidut asetyylikoliiniesteraase-inhibiittorit - Google Patents

Silybidut asetyylikoliiniesteraase-inhibiittorit Download PDF

Info

Publication number
FI953851A
FI953851A FI953851A FI953851A FI953851A FI 953851 A FI953851 A FI 953851A FI 953851 A FI953851 A FI 953851A FI 953851 A FI953851 A FI 953851A FI 953851 A FI953851 A FI 953851A
Authority
FI
Finland
Prior art keywords
silybidut
acetylcholinesterase inhibitors
compounds
methods
acetylcholinesterase
Prior art date
Application number
FI953851A
Other languages
English (en)
Swedish (sv)
Other versions
FI953851A0 (fi
FI111461B (fi
Inventor
Jean-Noel Collard
Jean-Marie Hornsperger
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI953851A0 publication Critical patent/FI953851A0/fi
Publication of FI953851A publication Critical patent/FI953851A/fi
Application granted granted Critical
Publication of FI111461B publication Critical patent/FI111461B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
FI953851A 1993-02-16 1995-08-15 Menetelmä terapeuttisesti käyttökelpoisten silyloitujen asetyylikoliiniesteraasi-inhibiittorien valmistamiseksi FI111461B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP93400385 1993-02-16
EP93400385A EP0611769A1 (en) 1993-02-16 1993-02-16 Silylated acetylcholinesterase inhibitors
US9400720 1994-01-25
PCT/US1994/000720 WO1994019356A1 (en) 1993-02-16 1994-01-25 Silylated acetylcholinesterase inhibitors

Publications (3)

Publication Number Publication Date
FI953851A0 FI953851A0 (fi) 1995-08-15
FI953851A true FI953851A (fi) 1995-08-15
FI111461B FI111461B (fi) 2003-07-31

Family

ID=8214682

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953851A FI111461B (fi) 1993-02-16 1995-08-15 Menetelmä terapeuttisesti käyttökelpoisten silyloitujen asetyylikoliiniesteraasi-inhibiittorien valmistamiseksi

Country Status (19)

Country Link
EP (2) EP0611769A1 (fi)
JP (1) JP3516955B2 (fi)
KR (1) KR100336547B1 (fi)
CN (1) CN1043575C (fi)
AT (1) ATE152725T1 (fi)
AU (1) AU672885B2 (fi)
CA (1) CA2154870C (fi)
DE (1) DE69403068T2 (fi)
DK (1) DK0684951T3 (fi)
ES (1) ES2104358T3 (fi)
FI (1) FI111461B (fi)
GR (1) GR3024151T3 (fi)
HU (1) HUT72736A (fi)
IL (1) IL108623A0 (fi)
MX (1) MX9401175A (fi)
NO (1) NO305517B1 (fi)
NZ (1) NZ262247A (fi)
WO (1) WO1994019356A1 (fi)
ZA (1) ZA94925B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
CN100431539C (zh) * 2004-01-12 2008-11-12 和泓生物技术(上海)有限公司 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
EP2091948B1 (en) 2006-11-30 2012-04-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
MX2009009234A (es) 2007-03-01 2009-12-01 Probiodrug Ag Uso nuevo de inhibidores de ciclasa de glutaminilo.
EP2865670B1 (en) 2007-04-18 2017-01-11 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
ES2548913T3 (es) 2009-09-11 2015-10-21 Probiodrug Ag Derivados heterocíclicos como inhibidores de glutaminil ciclasa
CN102905532A (zh) 2010-02-09 2013-01-30 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
AU2011226074B2 (en) 2010-03-10 2015-01-22 Vivoryon Therapeutics N.V. Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2014144801A1 (en) 2013-03-15 2014-09-18 Agenebio Inc. Methods and compositions for improving cognitive function
EA034167B8 (ru) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Фармацевтические композиции леветирацетама пролонгированного высвобождения
DK3461819T3 (da) 2017-09-29 2020-08-10 Probiodrug Ag Inhibitorer af glutaminylcyklase
CN112047973B (zh) * 2019-06-06 2022-11-18 上海科技大学 一种大麻素类化合物,其制备方法、组合物和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403713A1 (en) * 1989-06-22 1990-12-27 Merrell Dow Pharmaceuticals Inc. Novel acetylcholinesterase inhibitors

Also Published As

Publication number Publication date
MX9401175A (es) 1994-08-31
FI953851A0 (fi) 1995-08-15
NO953201L (no) 1995-08-15
NO953201D0 (no) 1995-08-15
IL108623A0 (en) 1994-05-30
DE69403068T2 (de) 1997-12-11
KR960701068A (ko) 1996-02-24
DK0684951T3 (da) 1997-05-26
AU6164194A (en) 1994-09-14
CN1117733A (zh) 1996-02-28
JPH08507059A (ja) 1996-07-30
WO1994019356A1 (en) 1994-09-01
ES2104358T3 (es) 1997-10-01
EP0684951B1 (en) 1997-05-07
GR3024151T3 (en) 1997-10-31
NO305517B1 (no) 1999-06-14
ZA94925B (en) 1994-08-25
CN1043575C (zh) 1999-06-09
JP3516955B2 (ja) 2004-04-05
AU672885B2 (en) 1996-10-17
EP0611769A1 (en) 1994-08-24
FI111461B (fi) 2003-07-31
HUT72736A (en) 1996-05-28
DE69403068D1 (en) 1997-06-12
KR100336547B1 (ko) 2002-11-02
CA2154870A1 (en) 1994-09-01
EP0684951A1 (en) 1995-12-06
ATE152725T1 (de) 1997-05-15
NZ262247A (en) 1996-01-26
CA2154870C (en) 1998-10-27

Similar Documents

Publication Publication Date Title
DK0701546T3 (da) Aromatiske acetylchlolinesteraseinhibitorer
ATE152725T1 (de) Silylierte acetylcholinesterase inhibitoren
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
MX9304638A (es) Composicion para tratar e inhibir las ulceras gastricas y duodenales.
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
HUT71550A (en) Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis
FR2720637B1 (fr) Compositions cosmétiques photoprotectrices à base d'un mélange synergétique de filtres et utilisations.
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
DE69432626D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
ITMI930571A1 (it) Procedimento ed apparecchiatura per l'analisi di composti volatili organici.
NO982582L (no) Fremgangsmaate for behandling av smerte
FI911510A0 (fi) Hydroximetylindolizidiner och -kinolizidiner.
DE59305800D1 (de) Werkzeug zur behandlung von oberflächen von bauteilen
ATE262527T1 (de) Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo(2.1.5-cd)indolizin-derivate

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

MM Patent lapsed